Advertisement

Topics

-#Takeda completes $60bn #Shire #acquisition -#Pfizer shut two plants in #India, 1700 #jobs at risk -BMS to acquire Celgene for $74bn -#AstraZeneca hire controversial #cancer doc -NICE rejects Novartis' Aimovig #migraine injection http://bit.ly/2M40KSm

13:00 EST 11 Jan 2019 | Pharmafile

- completes $60bn - shut two plants in , 1700 at risk -BMS to acquire Celgene for $74bn - hire controversial doc -NICE rejects Novartis' Aimovig injection http://bit.ly/2M40KSm 

Original Article: -#Takeda completes $60bn #Shire #acquisition -#Pfizer shut two plants in #India, 1700 #jobs at risk -BMS to acquire Celgene for $74bn -#AstraZeneca hire controversial #cancer doc -NICE rejects Novartis' Aimovig #migraine injection http://bit.ly/2M40KSm

NEXT ARTICLE

More From BioPortfolio on "-#Takeda completes $60bn #Shire #acquisition -#Pfizer shut two plants in #India, 1700 #jobs at risk -BMS to acquire Celgene for $74bn -#AstraZeneca hire controversial #cancer doc -NICE rejects Novartis' Aimovig #migraine injection http://bit.ly/2M40KSm"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...